Joshua Zeichner, MD; Brittany Craiglow, MD; Elizabeth Swanson, MD; Vikash Oza, MD; and Raj Chovatiya, MD, PhD, provide take-home messages for dermatologists treating pediatric patients with atopic dermatitis.
Dermatologist Laura Ferris, MD, PhD, discusses skin-related toxicities as a result of immunotherapies for the treatment and management of cancers.
Medical practices must go beyond simply offering competitive salaries and benefits packages to attract new talent and keep their best clinicians and administrative staff working for them.
Patient Cole Villaflor, his mother, and Michael Levy, MD, PhD, provide insights into Cole’s hyperhidrosis diagnosis and subsequent endoscopic thoracic sympathectomy surgery.
What are the special considerations for treating pediatric atopic dermatitis? Test your knowledge and hear more from an expert.
During an interview with Dermatology Times, Zirwas outlined modern allergens such as sulfites, dietary nickel, and acrylates.
Walter Liszewski, MD, shares insights into discrepancies between permanent makeup and decorative tattoos and which patients may benefit from permanent makeup.
Celebrating the Skin We're In seeks to advocate for health equity through community outreach and education efforts.
Dr Bhutani presents the case of a 15-year-old female with long standing atopic dermatitis and discusses the importance of balancing parental preferences for "natural" agents with effective pharmaceutical options. She also reviews the significance of patient assistance programs in facilitating patient access to and affordability of pharmaceutical therapies.
Desai emphasized that most dermatologists would rather biopsy a potential melanoma than miss one that could become deadly.
Aaron S. Farberg, MD, and Jeffrey Crowley, MD, share take-home messages on the impact of the generalized pustular psoriasis study.
Acne, molluscum, atopic dermatitis, and other dermatological disorders can be detrimental to quality of life for children and their families.
Scassellati Sforzolini discusses the significance of Galderma’s nemolizumab receiving 4 additional filing acceptances for prurigo nodularis and atopic dermatitis.
Misleading marketing and incomplete scientific data have led to widespread misinformation about botulinum toxin products.
Experts discuss enhancing patient outcomes, comparing clobetasol cream concentrations, and more.
Looking toward the future management of vitiligo, expert dermatologists close out their discussion on JAK inhibition and other novel therapy.
Biologics work by inhibiting inflammatory cytokines, but a small percentage of patients may experience “paradoxical psoriasis.”
Nada Elbuluk, MD, and David Rosmarin, MD, provide advice to physicians on the management of vitiligo.
Earn CME credit and learn how to optimize a multimodal treatment approach for hidradenitis suppurativa.
This review will explore various leukemia-related cutaneous findings and discuss the diagnosis and management of these conditions.
Decentralized clinical trials are emerging as a crucial avenue for transforming this gender bias and fostering inclusivity within health care research.
Increased COPD prevalence in patients with psoriasis likely reflects smoking correlation, according to researchers.
Renata Block, PA-C, and Karan Lal, DO, discuss the critical role of advanced practice providers in dermatology, the power of mentorship, and how collaborative learning improves patient outcomes.
November is Hyperhidrosis Awareness Month, and dermatology clinicians are gearing up for another month of raising awareness to improve patient outcomes.
The congenital ichthyosis session the 2024 AAD Annual Meeting covered real-world patient cases and treatments on the horizon.